<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Intraarterial administration of urokinase using Tracker microcatheter was performed in 11 patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> caused by embolic occlusion of the internal carotid or the middle cerebral artery </plain></SENT>
<SENT sid="1" pm="."><plain>Recanalization was observed in seven cases (64%) following the fibrinolytic therapy, and the time until recanalization from the start of the treatment was on the average 2.8 hours </plain></SENT>
<SENT sid="2" pm="."><plain>Recanalization was seen in five out of six cases that received superselective infusion of urokinase, while it was seen in two out of five cases that received selective infusion </plain></SENT>
<SENT sid="3" pm="."><plain>This study suggests that superselective infusion of urokinase is an excellent therapeutic method for embolic occlusion of the cerebral artery </plain></SENT>
</text></document>